Skip to Main Content

Paper Details

Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment.
Antiviral Res
70
2018
Author NameAffiliation
Fabio ZaniniStanford University
Claude M NagamineStanford University School of Medicine
Shirit EinavStanford University School of Medicine
  • 1 - 3

Datasets

Release 1.2